Metastasis is the spread of cancer from its' site of origin or primary site to a new site in the body. For example, breast cancer can often metastasize to the bone. Metastasis accounts for 90% of all cancer-related deaths worldwide and is not curable. It is considered a terminal disease, yet metastasis research is underfunded as the majority (~95%) of cancer research funds worldwide go to cancer prevention and early detection, and not cancer metastasis.
The Metastasis Research Society (MRS) is a U.S.-registered non-profit professional society with both U.S. and international members. We are based out of Tampa, FL. The majority of our members are scientific researchers from industry or academia and clinical oncologists. All of our members have research projects focused on cancer metastasis specifically.
Our society supports research that examines the process of metastasis at the cellular, molecular and biochemical levels, and identifies and evaluates therapeutics for their ability to control or reduce metastases in preclinical models.
Our scientific researchers work with clinical colleagues to design and implement clinical trials to translate laboratory findings to effective therapies in the clinic. We are striving for a greater incorporation of metastasis-related outcomes into clinical trial design.
We are also branching out as a voice that can serve the metastatic patient community at large by increasing awareness about what metastasis is, why it is so critical to fund metastatic cancer research, and we are designing programs to help educate cancer communities about many aspects of being diagnosed with metastatic cancer.